ResearchSafe

MGF (Mechano Growth Factor) (Mechano Growth Factor (IGF-1Ec splice variant))

Category: Muscle Growth. Status: Research compound.

An IGF-1 splice variant produced locally in muscle from mechanical stimulation. Activates satellite stem cells initiating repair and growth response to training.

How it works

Unique E-domain activates quiescent satellite cells for proliferation. Distinct from IGF-1Ea which drives differentiation. PEGylated form extends short half-life.

Key facts

  • Molecular weight: 2,867 Da (synthetic fragment)
  • Half-life: 5-7 min (native) / 24-48h (PEGylated)
  • Bioavailability: High (local IM)
  • Storage: Lyophilized: -20°C. Reconstituted: 2-8°C for 7 days.

Dosing overview

  • Typical dose: 100-200 mcg PEG-MGF
  • Frequency: 2-3x per week
  • Duration: 4-6 weeks
  • Route: Intramuscular (local)

Reported benefits

  • Satellite cell activation
  • Muscle-specific growth
  • Repair response enhancement
  • Synergistic with training
  • Local hypertrophy

Possible side effects

  • Injection site soreness
  • Rapid degradation (non-PEG)
  • Limited human data

Research

  • MGF expression in human muscle post-exercise (2020): MGF mRNA increased 400% within 4 hours post-training, preceding satellite cell activation.
  • PEGylated MGF for muscle regeneration (2021): Increased satellite cells by 250% and accelerated functional recovery by 40%.

Compare MGF (Mechano Growth Factor)

Research and educational reference only. Not medical advice.